» Articles » PMID: 25577237

Role of Homocysteine in the Development of Cardiovascular Disease

Overview
Journal Nutr J
Publisher Biomed Central
Date 2015 Jan 12
PMID 25577237
Citations 383
Authors
Affiliations
Soon will be listed here.
Abstract

It is well known that neuronal damage following a stroke has been attributed to the over stimulation of excitatory amino acids such as glutamate and aspartate through activation of NMDA receptors. The brain is exposed to most of the constituents of plasma including homocysteine as a result of the disruption of the blood-brain barrier after stroke, head trauma and stress. The question, therefore, arises as to whether or not homocysteine is able to selectively stimulate the release of excitatory amino acids in stroke. This review article will address the importance of homocysteine in nervous system specifically how these amino acids may trigger the release of catecholamines. Our data will thus strengthen the view that a mechanism for the association of hyperhomocysteinemia with increased brain lesion in stroke. As hypothalamus also controls the cardiac function via sympathetic system, the contractility of heart will be compromised. Homocysteine is also known to mediate cardiovascular problems by its adverse effects on cardiovascular endothelium and smooth muscle cells with resultant alterations in subclinical arterial structure and function. The present review will thus summarize both central and peripheral effects of homocysteine and will highlight some of the controversies associated with hyperhomocysteinemia-induced cardiovascular problems.

Citing Articles

Blood-Based DNA Methylation Biomarkers to Identify Risk and Progression of Cardiovascular Disease.

Willmer T, Mabasa L, Sharma J, Muller C, Johnson R Int J Mol Sci. 2025; 26(5).

PMID: 40076974 PMC: 11900213. DOI: 10.3390/ijms26052355.


Homocysteine levels and cardiovascular disease risk factors in chronic kidney disease (CKD), hypertensive and healthy Nigerian adults: a comparative retrospective study.

Adeoye M, Hamdallah H, Adeoye A BMJ Open. 2025; 15(3):e089644.

PMID: 40074258 PMC: 11904321. DOI: 10.1136/bmjopen-2024-089644.


Effects of caregiving burden on serum homocysteine and folate levels in spouses of patients with cognitive impairment.

Jeong H, Park S, Kim J, Kim S, Jeon S J Alzheimers Dis Rep. 2025; 9:25424823251322499.

PMID: 40034509 PMC: 11864268. DOI: 10.1177/25424823251322499.


Plasma homocysteine level and trajectories in association with longitudinal increase in plasma neurofilament light among urban adults.

Beydoun M, Noren Hooten N, Georgescu M, Beydoun H, Fanelli-Kuczmarski M, Weiss J Geroscience. 2025; .

PMID: 39969743 DOI: 10.1007/s11357-025-01567-z.


Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside.

Tian W, Ju J, Guan B, Wang T, Zhang J, Song L Ann Med. 2025; 57(1):2457527.

PMID: 39898976 PMC: 11792134. DOI: 10.1080/07853890.2025.2457527.


References
1.
Zhang S, Bai Y, Luo L, Xiao W, Wu H, Ye P . Association between serum homocysteine and arterial stiffness in elderly: a community-based study. J Geriatr Cardiol. 2014; 11(1):32-8. PMC: 3981981. DOI: 10.3969/j.issn.1671-5411.2014.01.007. View

2.
Veeranna V, Zalawadiya S, Niraj A, Pradhan J, Ference B, Burack R . Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 2011; 58(10):1025-33. DOI: 10.1016/j.jacc.2011.05.028. View

3.
Wuerthele S, Yasuda R, Freed W, Hoffer B . The effect of local application of homocysteine on neuronal activity in the central nervous system of the rat. Life Sci. 1982; 31(24):2683-91. DOI: 10.1016/0024-3205(82)90712-3. View

4.
Lim U, Cassano P . Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2002; 156(12):1105-13. DOI: 10.1093/aje/kwf157. View

5.
Loscalzo J, Handy D . Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ. 2014; 4(2):169-74. PMC: 4070783. DOI: 10.1086/675979. View